<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reduced levels of the cyclin-dependent kinase inhibitor p27(Kip1) connote poor prognosis in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and in precancerous B cells and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> arising in Emu-Myc transgenic mice, p27(Kip1) expression is markedly reduced </plain></SENT>
<SENT sid="2" pm="."><plain>We show that the transcription of the Cks1 component of the SCF(Skp2) complex that is necessary for p27(Kip1) ubiquitylation and degradation is induced by Myc </plain></SENT>
<SENT sid="3" pm="."><plain>Further, Cks1 expression is elevated in precancerous Emu-Myc B cells, and high levels of Cks1 are also a hallmark of Emu-Myc <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and of human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Finally, loss of Cks1 in Emu-Myc B cells elevates p27(Kip1) levels, reduces proliferation and markedly delays <z:hpo ids='HP_0002665'>lymphoma</z:hpo> development and dissemination of disease </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, Myc suppresses p27(Kip1) expression, accelerates cell proliferation and promotes <z:mp ids='MP_0002006'>tumorigenesis</z:mp> at least in part through its ability to selectively induce Cks1 </plain></SENT>
</text></document>